Nordics Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

  Dec 2025   | Format: PDF DataSheet |   Pages: 110+ | Type: Niche Industry Report |    Authors: Mahesh Y (Manager)  

 

Nordics Diagnostic and Monitoring Devices Market Outlook

  • The market in Nordics was valued at USD 3.10 billion in 2024.
  • The Nordics Diagnostic and Monitoring Devices Market is projected to grow at a CAGR of 6.1%, during the forecast window, to reach USD 5.16 billion in 2033.
  • DataCube Research Report (Nov 2025): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.

Industry Assessment Overview

Industry Findings: The Nordics are consolidating as an enterprise-grade imaging and oncology cluster where procurement favors vendors who combine high-quality hardware with regional service footprints. Large hospital systems and cancer centres in Sweden and Norway are prioritizing integrated imaging-to-therapy workflows and pathology digitization, creating premium demand for vendors that support enterprise imaging, treatment planning and service-level continuity.

Industry Progression: Market movement is concrete: a major Norwegian health region expanded its enterprise imaging and pathology contract with Sectra, extending digital pathology and radiology coverage to improve cancer workflows (Dec-2024). That contract demonstrates how Nordic health systems are moving from point upgrades to multi-year, vendor-platform commitments that raise the bar on integration capability and long-term support.

Industry Player Insights: A large number of providers operate in Nordics including GE HealthCare, Elekta, Sectra, and Getinge etc. Nordic procurement is tilting toward platform suppliers that combine imaging hardware, oncology workflows and enterprise imaging software. Elekta’s product refreshes and ongoing partnership activity (Jul-2024) and Sectra’s Dec-2024 enterprise pathology expansion show how vendors that link radiology, pathology and therapy gain multi-site, long-term deals; Getinge’s 2024 acquisitions strengthened service and organ-preservation offerings supporting acute care buyers.

*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation. [Learn more]

Market Scope Framework

Offering

  • Diagnostic Instruments (Lab Analyzers)
  • Point-of-Care Devices
  • Patient Monitoring Systems
  • Imaging Systems
  • Wearable & Consumer Monitoring Devices
  • In Vitro Diagnostics Consumables & Reagents
  • Implantable Monitoring Devices

Technology

  • Imaging-Based Modalities
  • Biochemical Assay-Based Devices
  • Molecular Diagnostics Hardware
  • Electrochemical & Biosensing Devices
  • Optical & Spectroscopic Systems
  • Physiological Monitoring Devices
  • Wearable / Wireless Monitoring Hardware

Clinical Application

  • Cardiovascular Diagnostics & Monitoring
  • Infectious Disease Diagnostics
  • Oncology Diagnostics
  • Metabolic & Endocrine Diagnostics
  • Neurology Monitoring
  • Respiratory Diagnostics & Monitoring
  • Maternal & Neonatal Monitoring
  • General Health & Wellness / Multispecialty

Distribution Channel

  • Direct Sales
  • Distributor / Dealer Channel
  • Group Purchasing Organizations (GPOs) / Buying Consortia
  • E-commerce & Retail Marketplaces

End User

  • Hospitals & Acute Care Facilities
  • Clinical & Reference Laboratories
  • Ambulatory & Physician Clinics
  • Pharmacies & Retail Health Clinics
  • Home Care / Direct-to-Consumer
  • Research & Academic Institutions
×

Request Sample

CAPTCHA Refresh